Congressman Jeff Duncan led a bipartisan letter to Speaker Nancy Pelosi and Republican Leader Kevin McCarthy to prevent the inclusion of a controversial provision that inevitably delays the final Food and Drug Administration (FDA) User Fee program’s reauthorization.
“I led a bipartisan letter with 14 of my fellow Members of Congress to Speaker Pelosi and Leader McCarthy to prevent the inclusion of a controversial provision that inevitably delays the final Food and Drug Administration (FDA) User Fee program’s reauthorization,” said Congressman Jeff Duncan. “House Leadership and the Energy and Commerce Committee worked hard to make the House version of the reauthorization bipartisan and free of controversy so that it could pass as quickly as possible. Unfortunately, the Senate has undermined these efforts by including mandatory product listing for dietary supplements in the language. The User Fee programs reauthorization is not the appropriate vehicle to advance this provision, and its inclusion will necessitate further debate that will only delay passage of the underlying legislation.”
